CVS Health reported a 5.4% increase in third-quarter revenues to $108.4 billion, driven by growth in its Health Services and Health Care Benefits segments. GAAP diluted EPS improved to $1.68 from a loss of $3.13 last year, while adjusted EPS rose to $2.09. The company raised its full-year 2026 guidance, expecting GAAP diluted EPS of at least $6.98 and adjusted EPS of at least $8.20, alongside increased cash flow from operations guidance to $15.5 billion. CVS continues to focus on improving consumer experience and lowering healthcare costs amid ongoing cost pressures and economic uncertainties.
CVS Health shares trade at USD 92.35 on Pluang as of Nov 04, 2026 18:41 WIB, showing a modest 1.03% gain for the day. The stock's market cap stands at $116.91 billion, reflecting strong investor interest following the company’s raised full-year guidance. Pluang users show a strong buying sentiment with 91% of order activity favoring purchases, aligning with the positive outlook from CVS's recent quarterly results.
CVS Health announced plans to split into two separate public companies by mid-2028, undoing its $78 billion acquisition of insurer Aetna and breaking up its integrated healthcare business. The split will separate CVS's 9,000 retail pharmacies from it...
CVS Health announced plans to separate into two independent publicly traded companies by the first half of 2028. One company will focus on healthcare solutions, including Aetna and CVS Caremark, while the other will be a retail pharmacy company with ...
CVS Health will divide into two separate companies, separating its retail pharmacy business from its insurance and pharmacy-benefit operations. One company will keep the CVS Health name and be led by CEO David Joyner. This move reverses CVS's previou...
CVS Health and McDonald's are set to report earnings soon, with both stocks labeled 'too cheap to ignore' by Jim Cramer despite underlying risks. CVS has shown strong earnings growth and raised its full-year guidance, but faces potential policy risks...
